New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 5, 2012
08:04 EDTTHOR, MDT, ABMDThe FDA Circulatory Systems Devices Panel holds a meeting
The Panel discusses and makes recommendations regarding the 515(i) order issued by the FDA on April 9, 2009 , for the external counter-pulsating (ECP) devices and the Intra-aortic balloon and control systems, one of the remaining pre-Amendment Class III devices, in a meeting being held in Gaithersburg, Maryland on December 5 at 8 am. Webcast Link
News For MDT;THOR;ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:02 EDTMDTMedtronic announces Irish High Court approval of share premium reduction
Subscribe for More Information
February 24, 2015
13:02 EDTMDTMedtronic confirms FDA approval of VenaSeal closure system
Subscribe for More Information
February 23, 2015
08:40 EDTMDTMedtronic acquires Advanced Uro-Solutions, terms not disclosed
Medtronic announced that it has acquired Advanced Uro-Solutions, a privately-held developer of neurostimulation products for the treatment of bladder control issues based in Elizabethton, Tennessee. Terms of the acquisition agreement, which closed in December 2014, were not disclosed.
February 20, 2015
12:19 EDTMDTFDA approves closure system to permanently treat varicose veins
Subscribe for More Information
February 19, 2015
16:15 EDTMDTMedtronic SANTE trial data show sustained safety, improvements in QOLIE-31
Subscribe for More Information
February 17, 2015
09:29 EDTMDTMedtronic says FY16 constant currency revenue may be up mid-single digit range
Subscribe for More Information
09:27 EDTMDTMedtronic, Covidien targeting over $850M in cost synergies through FY18
Subscribe for More Information
08:49 EDTMDTMedtronic sees being at high end of Q4 revenue growth range
Subscribe for More Information
08:00 EDTABMDAbiomed price target raised to $72 from $60 at Leerink
Subscribe for More Information
08:00 EDTABMDAbiomed price target raised to $72 from $60 at Leerink
Leerink raised its price target for Abiomed shares to $72 saying it believes recent adoption momentum is sustainable as the company continues to penetrate the emergent and high risk percutaneous coronary intervention patient population. It reiterates an Outperform rating on the stock.
07:19 EDTMDTMedtronic sees Q4 revenue up 4%-6%
Subscribe for More Information
07:18 EDTMDTMedtronic reports Q3 EPS $1.01, consensus 97c
Subscribe for More Information
February 16, 2015
13:59 EDTMDTMedtronic receives expanded indications of the Vertex Reconstruction System
Subscribe for More Information
12:30 EDTMDTMedtronic announces CE mark, European launch of the Euphora catheter
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use